Eris Lifesciences Approves ₹50 Crore Acquisition of Branded Probiotic Products from Velbiom Probiotics
Published on: March 20, 2026, 3:41 p.m. | Source: scanx.trade
Eris Lifesciences has approved the acquisition of branded probiotic products from Velbiom Probiotics for ₹50 crores. The target business has shown consistent revenue performance over three years, generating ₹16.02 crores, ₹19.64 crores, and ₹17.56 crores respectively. This strategic acquisition expands Eris Lifesciences' portfolio into the probiotic segment through established branded products.
